Harvoni (Ledipasvir/ Sofosbuvir)
Harvoni (Ledipasvir/ Sofosbuvir)
Harvoni, a breakthrough in Hepatitis C treatment, combines Ledipasvir and Sofosbuvir in one tablet. It is primarily intended to treat chronic Hepatitis C virus (HCV) genotypes 1, 4, 5, and 6 in adults and children over the age of 3. Harvoni's once-daily oral regimen provides a cure for many patients suffering from this chronic illness, opening a new age of HCV treatment with its high cure rates and simpler therapy schedule.Why Choose Harvoni (Ledipasvir/ Sofosbuvir)?
- High Cure Rate: Harvoni has been reported to cure up to 99% of individuals with Hepatitis C genotypes 1, 4, 5, and 6 in just 12 weeks of treatment, including many patients without or with compensated cirrhosis.
- Single Tablet Regimen: Harvoni is a single-tablet regimen that combines two antiviral drugs, Ledipasvir and Sofosbuvir, eliminating the need for interferon or ribavirin for the majority of patients.
- Reduced Treatment Duration: For many patients, treatment can be finished in 8 to 12 weeks, which is much shorter than previous treatment alternatives.
- Well-Tolerated: Harvoni is usually well-tolerated, with the most frequent adverse effects being fatigue and headache.
How to Use Harvoni (Ledipasvir/ Sofosbuvir)?
- Harvoni is taken once a day, with or without meals.
- You must take Harvoni exactly as directed by your healthcare professional for the whole duration of the therapy, even if your symptoms improve.
- Do not change your dose or stop taking Harvoni without first consulting your doctor.
Important Safety Information about Harvoni
- Before beginning Harvoni, tell your doctor about all of your medical conditions, especially whether you have hepatitis B, liver disorders other than hepatitis C, or have undergone a liver transplant.
- Inform your doctor about all of the medications you take, including prescription and over-the-counter medications, vitamins, and herbal supplements. Harvoni can interact with other medications, resulting in serious side effects.
- The most common Harvoni side effects are weariness and headache. Serious adverse effects are uncommon but may occur.
Fact Table
| Facts | Details |
| Generic Name | Ledipasvir/ Sofosbuvir |
| Brand Name | Harvoni |
| Approved By | FDA (Food and Drug Administration) |
| Date of Approval | October 2014 |
| Indications | Treatment of chronic Hepatitis C virus (HCV) genotypes 1, 4, 5, and 6 in adults and children over 3 years of age |
| Dosage Form | Oral tablet |
| Strengths | 90 mg Ledipasvir/400 mg Sofosbuvir |
| Recommended Dosage | One tablet daily |
| Treatment Duration | 8, 12, or 24 weeks, depending on patient-specific factors including the presence of cirrhosis, treatment history, and viral genotype |
| Mechanism of Action | Ledipasvir is an NS5A inhibitor, and Sofosbuvir is a nucleotide polymerase inhibitor. Together, they prevent the hepatitis C virus from multiplying and spreading. |
| Common Side Effects | Fatigue, headache |
| Drug Interactions | Significant interactions with amiodarone, anticonvulsants, antituberculous agents, herbal supplements like St. John’s Wort, and HIV antiviral regimens |
| Contraindications | Known hypersensitivity to Ledipasvir, Sofosbuvir, or any component of the formulation |
| Pregnancy Category | Category B (No evidence of risk in humans) |
Common Side Effects
Like all medications, Harvoni (Ledipasvir/ Sofosbuvir) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.- Fatigue
- Headache
- Nausea
- Insomnia
- Cough
How Can You Buy Harvoni (Ledipasvir/ Sofosbuvir)?
You can order Harvoni (Ledipasvir/ Sofosbuvir) using these methods on our website:- Order Online
- Order by Phone
- Order by Fax
- Order your refills
